These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 30675193)

  • 1. SUN2: A potential therapeutic target in cancer.
    Chen X; Chen Y; Huang HM; Li HD; Bu FT; Pan XY; Yang Y; Li WX; Li XF; Huang C; Meng XM; Li J
    Oncol Lett; 2019 Feb; 17(2):1401-1408. PubMed ID: 30675193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SUN2 exerts tumor suppressor functions by suppressing the Warburg effect in lung cancer.
    Lv XB; Liu L; Cheng C; Yu B; Xiong L; Hu K; Tang J; Zeng L; Sang Y
    Sci Rep; 2015 Dec; 5():17940. PubMed ID: 26658802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated Sad1 and UNC84 Domain Containing 2 (SUN2) level inhibits cell growth and aerobic glycolysis in oral cancer through reducing the expressions of glucose transporter 1 (GLUT1) and lactate dehydrogenase A (LDHA).
    Liao Y; Zhao T; Li LY; Wang FQ
    J Dent Sci; 2021 Jan; 16(1):460-466. PubMed ID: 33384835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SUN2 Modulates HIV-1 Infection and Latency through Association with Lamin A/C To Maintain the Repressive Chromatin.
    Sun WW; Jiao S; Sun L; Zhou Z; Jin X; Wang JH
    mBio; 2018 May; 9(3):. PubMed ID: 29717016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of Sun2 promotes the progression of prostate cancer by regulating fatty acid oxidation.
    Yajun C; Chen Y; Xiaosa L; Xiao W; Jia C; Zhong W; Bin X
    Oncotarget; 2017 Oct; 8(52):89620-89630. PubMed ID: 29163775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of SUN2 by DNA methylation is associated with HSCs activation and hepatic fibrosis.
    Chen X; Li WX; Chen Y; Li XF; Li HD; Huang HM; Bu FT; Pan XY; Yang Y; Huang C; Meng XM; Li J
    Cell Death Dis; 2018 Oct; 9(10):1021. PubMed ID: 30282980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of SUN2, a novel tumor suppressor, mediates miR-221/222-induced malignancy in central nervous system embryonal tumors.
    Hsieh TH; Chien CL; Lee YH; Lin CI; Hsieh JY; Chao ME; Liu DJ; Chu SS; Chen W; Lin SC; Ho DM; Liu RS; Lin CH; Wong TT; Wang HW
    Carcinogenesis; 2014 Oct; 35(10):2164-74. PubMed ID: 24832085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SUN2 Silencing Impairs CD4 T Cell Proliferation and Alters Sensitivity to HIV-1 Infection Independently of Cyclophilin A.
    Donahue DA; Porrot F; Couespel N; Schwartz O
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SUN2 Overexpression Deforms Nuclear Shape and Inhibits HIV.
    Donahue DA; Amraoui S; di Nunzio F; Kieffer C; Porrot F; Opp S; Diaz-Griffero F; Casartelli N; Schwartz O
    J Virol; 2016 Apr; 90(8):4199-4214. PubMed ID: 26865710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sun1 deficiency leads to cerebellar ataxia in mice.
    Wang JY; Yu IS; Huang CC; Chen CY; Wang WP; Lin SW; Jeang KT; Chi YH
    Dis Model Mech; 2015 Aug; 8(8):957-67. PubMed ID: 26035387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-talk between microtubules and the linker of nucleoskeleton complex plays a critical role in the adipogenesis of human adipose-derived stem cells.
    Yang Y; Qu R; Fan T; Zhu X; Feng Y; Yang Y; Deng T; Peng Y; Huang W; Ouyang J; Dai J
    Stem Cell Res Ther; 2018 May; 9(1):125. PubMed ID: 29720241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global loss of a nuclear lamina component, lamin A/C, and LINC complex components SUN1, SUN2, and nesprin-2 in breast cancer.
    Matsumoto A; Hieda M; Yokoyama Y; Nishioka Y; Yoshidome K; Tsujimoto M; Matsuura N
    Cancer Med; 2015 Oct; 4(10):1547-57. PubMed ID: 26175118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SUN2 mediates calcium-triggered nuclear actin polymerization to cluster active RNA polymerase II.
    Ulferts S; Grosse R
    EMBO Rep; 2024 Sep; ():. PubMed ID: 39317734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A molecular model for LINC complex regulation: activation of SUN2 for KASH binding.
    Jahed Z; Vu UT; Fadavi D; Ke H; Rathish A; Kim SCJ; Feng W; Mofrad MRK
    Mol Biol Cell; 2018 Aug; 29(16):2012-2023. PubMed ID: 29995584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrity of the Linker of Nucleoskeleton and Cytoskeleton Is Required for Efficient Herpesvirus Nuclear Egress.
    Klupp BG; Hellberg T; Granzow H; Franzke K; Dominguez Gonzalez B; Goodchild RE; Mettenleiter TC
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
    Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
    Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Jab1/COPS5 as a Novel Biomarker for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Human Cancer.
    Liu G; Claret FX; Zhou F; Pan Y
    Front Pharmacol; 2018; 9():135. PubMed ID: 29535627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The roles of oncogenic miRNAs and their therapeutic importance in breast cancer.
    O'Bryan S; Dong S; Mathis JM; Alahari SK
    Eur J Cancer; 2017 Feb; 72():1-11. PubMed ID: 27997852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear Envelope Protein SUN2 Promotes Cyclophilin-A-Dependent Steps of HIV Replication.
    Lahaye X; Satoh T; Gentili M; Cerboni S; Silvin A; Conrad C; Ahmed-Belkacem A; Rodriguez EC; Guichou JF; Bosquet N; Piel M; Le Grand R; King MC; Pawlotsky JM; Manel N
    Cell Rep; 2016 Apr; 15(4):879-892. PubMed ID: 27149839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA‑3666 inhibits breast cancer cell proliferation by targeting sirtuin 7.
    Li D; Li L
    Mol Med Rep; 2017 Dec; 16(6):8493-8500. PubMed ID: 28944911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.